1. Home
  2. NTWK vs SCLX Comparison

NTWK vs SCLX Comparison

Compare NTWK & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • SCLX
  • Stock Information
  • Founded
  • NTWK 1997
  • SCLX 2011
  • Country
  • NTWK United States
  • SCLX United States
  • Employees
  • NTWK N/A
  • SCLX N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • SCLX Health Care
  • Exchange
  • NTWK Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • NTWK 28.0M
  • SCLX 28.4M
  • IPO Year
  • NTWK 1998
  • SCLX N/A
  • Fundamental
  • Price
  • NTWK $2.81
  • SCLX $4.67
  • Analyst Decision
  • NTWK
  • SCLX Strong Buy
  • Analyst Count
  • NTWK 0
  • SCLX 4
  • Target Price
  • NTWK N/A
  • SCLX $396.67
  • AVG Volume (30 Days)
  • NTWK 18.4K
  • SCLX 206.3K
  • Earning Date
  • NTWK 05-14-2025
  • SCLX 05-23-2025
  • Dividend Yield
  • NTWK N/A
  • SCLX N/A
  • EPS Growth
  • NTWK N/A
  • SCLX N/A
  • EPS
  • NTWK N/A
  • SCLX N/A
  • Revenue
  • NTWK $62,048,128.00
  • SCLX $56,590,000.00
  • Revenue This Year
  • NTWK N/A
  • SCLX $115.30
  • Revenue Next Year
  • NTWK N/A
  • SCLX $73.33
  • P/E Ratio
  • NTWK N/A
  • SCLX N/A
  • Revenue Growth
  • NTWK 9.28
  • SCLX 21.07
  • 52 Week Low
  • NTWK $2.14
  • SCLX $3.60
  • 52 Week High
  • NTWK $3.34
  • SCLX $80.50
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 71.62
  • SCLX 39.15
  • Support Level
  • NTWK $2.34
  • SCLX $3.92
  • Resistance Level
  • NTWK $2.48
  • SCLX $6.13
  • Average True Range (ATR)
  • NTWK 0.10
  • SCLX 0.69
  • MACD
  • NTWK 0.03
  • SCLX 0.13
  • Stochastic Oscillator
  • NTWK 85.25
  • SCLX 32.56

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: